Our new data shows that an urgent intervention is needed in diabetes care and type 2 diabetes prevention to lower the number of people living with diabetes or prediabetes. Savefor later Page saved!

The NHS had been facing supply issues with glucagon-like peptide receptor agonists (GLP-1 RAs, or GLP-1 analogues), a range of drugs used for managing blood glucose levels in people with type 2 ...

Jasmin Notarangelo, a young British science writer, has won the 2024 Young Science Writer of the Year award for her essay about type 1 diabetes and technology.

In our January research highlights, we look at new research into how AI-powered screening could spot type 2 diabetes risk years in advance, and a new study into genetically altered beta cell therapy ...

We take a look at some of the exciting diabetes research developments announced in January, and what the findings could mean for people living with or affected by diabetes. Type 2 risk in South Asian ...

We are aware of reports regarding supply issues of insulin in the UK. Some of these reports are of insulins that are being discontinued and some are where there is a temporary shortage. Here’s the ...

There are currently shortages of the Fiasp FlexTouch insulin pen which could affect people living with diabetes who take Fiasp insulin. Here’s what you need to know.

Type 1 Grand Challenge: Improving Treg immunotherapy success by administering therapy at different times of day (Dr James Pearson’s Root Causes Programme Grant project) ...